Last Updated: 28 Aug 2025
Source: Statifacts
The global Pharmaceutical Grade Salidroside market size was evaluated at USD 423 million in 2024 and is expected to grow around USD 1067.6 million by 2034, registering a CAGR of 9.7% from 2025 to 2034.
Reports Attributes | Statistics |
Market Size in 2024 | USD 423 Million |
Market Size in 2025 | USD 464.03 Million |
Market Size in 2031 | USD 808.7 Million |
Market Size by 2034 | USD 1067.6 Million |
CAGR 2025 to 2034 | 9.7% |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
Published by Deepa Pandey
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Purity≥98% | 190.35 | 207.89 | 227.03 | 247.94 | 270.76 | 295.68 | 322.89 | 352.59 | 385.02 | 420.42 | 459.07 |
Purity≥99% | 169.20 | 186.54 | 205.65 | 226.72 | 249.93 | 275.52 | 303.72 | 334.80 | 369.05 | 406.80 | 448.39 |
Others | 63.45 | 69.60 | 76.36 | 83.76 | 91.89 | 100.80 | 110.58 | 121.30 | 133.07 | 145.98 | 160.14 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Medicine | 253.80 | 277.49 | 303.39 | 331.70 | 362.65 | 396.48 | 433.47 | 473.90 | 518.09 | 566.40 | 619.21 |
Health Supplements and Dietary Supplements | 169.20 | 186.54 | 205.65 | 226.72 | 249.93 | 275.52 | 303.72 | 334.80 | 369.05 | 406.80 | 448.39 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
North America | 126.90 | 138.28 | 150.68 | 164.18 | 178.88 | 194.88 | 212.31 | 231.29 | 251.95 | 274.44 | 298.93 |
Europe | 148.05 | 163.80 | 181.22 | 200.47 | 221.76 | 245.28 | 271.29 | 300.03 | 331.79 | 366.89 | 405.69 |
Asia Pacific | 84.60 | 92.34 | 100.79 | 110.01 | 120.07 | 131.04 | 143.02 | 156.08 | 170.33 | 185.88 | 202.84 |
Latin America | 33.84 | 37.12 | 40.72 | 44.67 | 49.01 | 53.76 | 58.98 | 64.70 | 70.97 | 77.86 | 85.41 |
Middle East and Africa | 29.61 | 32.48 | 35.63 | 39.09 | 42.88 | 47.04 | 51.60 | 56.61 | 62.10 | 68.12 | 74.73 |
Last Updated: 28 Aug 2025
Source: Statifacts
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Purity≥98% | 190.35 | 207.89 | 227.03 | 247.94 | 270.76 | 295.68 | 322.89 | 352.59 | 385.02 | 420.42 | 459.07 |
Purity≥99% | 169.20 | 186.54 | 205.65 | 226.72 | 249.93 | 275.52 | 303.72 | 334.80 | 369.05 | 406.80 | 448.39 |
Others | 63.45 | 69.60 | 76.36 | 83.76 | 91.89 | 100.80 | 110.58 | 121.30 | 133.07 | 145.98 | 160.14 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
Medicine | 253.80 | 277.49 | 303.39 | 331.70 | 362.65 | 396.48 | 433.47 | 473.90 | 518.09 | 566.40 | 619.21 |
Health Supplements and Dietary Supplements | 169.20 | 186.54 | 205.65 | 226.72 | 249.93 | 275.52 | 303.72 | 334.80 | 369.05 | 406.80 | 448.39 |
Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
---|---|---|---|---|---|---|---|---|---|---|---|
North America | 126.90 | 138.28 | 150.68 | 164.18 | 178.88 | 194.88 | 212.31 | 231.29 | 251.95 | 274.44 | 298.93 |
Europe | 148.05 | 163.80 | 181.22 | 200.47 | 221.76 | 245.28 | 271.29 | 300.03 | 331.79 | 366.89 | 405.69 |
Asia Pacific | 84.60 | 92.34 | 100.79 | 110.01 | 120.07 | 131.04 | 143.02 | 156.08 | 170.33 | 185.88 | 202.84 |
Latin America | 33.84 | 37.12 | 40.72 | 44.67 | 49.01 | 53.76 | 58.98 | 64.70 | 70.97 | 77.86 | 85.41 |
Middle East and Africa | 29.61 | 32.48 | 35.63 | 39.09 | 42.88 | 47.04 | 51.60 | 56.61 | 62.10 | 68.12 | 74.73 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from